Page last updated: 2024-08-26

fulvestrant and formazans

fulvestrant has been researched along with formazans in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cerbón, M; García-López, P; Mohar-Betancourt, A; Pérez-Cárdenas, E; Rodríguez-Dorantes, M	1

Other Studies

1 other study(ies) available for fulvestrant and formazans

Article	Year
Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines. Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:6 Topics: Antineoplastic Agents; Carcinoma; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Flow Cytometry; Formazans; Fulvestrant; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Uterine Cervical Neoplasms	2004

Article

Year

Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.

Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:6

Topics: Antineoplastic Agents; Carcinoma; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Flow Cytometry; Formazans; Fulvestrant; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Uterine Cervical Neoplasms

2004